Everest Medicines Limited (HKG:1952)

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Pharmaceutical Products	125.93M	12.79M	54.00K
Pharmaceutical Products Growth	884.46%	23588.89%	-
Total	125.93M	12.79M	54.00K
Total Growth	884.46%	23588.89%	-

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Mainland China	125.93M	12.79M	54.00K
Mainland China Growth	884.46%	23588.89%	-
Total	125.93M	12.79M	54.00K
Total Growth	884.46%	23588.89%	-

Source: S&P Global Market Intelligence.